Skip to content

Patient-Reported Outcome Measures (PROMs) in patients with oral cancer

Implementation of Patient-Reported Outcome Measures (PROMs) in Patients Undergoing Oral Cancer Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/101489
Enrollment
150
Registered
2026-01-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C021- Malignant neoplasm of border of tongue Health Condition 2: C020- Malignant neoplasm of dorsal surface of tongue Health Condition 3: C049- Malignant neoplasm of floor of mouth, unspecified Health Condition 4: C039- Malignant neoplasm of gum, unspecified Health Condition 5: C004- Malignant neoplasm of lower lip, inner aspect Health Condition 6: C069- Malignant neoplasm of mouth, unspecified Health Condition 7: C059- Malignant neoplasm of palate, unspecified Health Conditi

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Tata Memorial Centre Research Administration Council
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients with histologically proven oral squamous cell carcinoma, with plans for surgery with or without adjuvant therapy for oral cancer. Patients will be enrolled within a month of diagnosis, and the first PROM will be assessed the night before surgery.

Exclusion criteria

Exclusion criteria: Patients with cognitive impairments to whom the content of questionnaires cannot be adequately explained.

Design outcomes

Primary

MeasureTime frame
Feasibility of PROMs in routine clinical practice based on recruitment and retention.Timepoint: 8 months after surgery

Secondary

MeasureTime frame
To assess clinician s perception of clinical benefit to patients in terms of intervention-based decisions made after completion of PROMsTimepoint: 2 months;To assess patient and caregiver acceptabilityTimepoint: 8 months;To identify reasons for discontinuationTimepoint: 8 months

Countries

India

Contacts

Public ContactDr Burhanuddin Qayyumi

Homi Bhabha Cancer Hospital and Research Centre

qburhan@gmail.com9566170436

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026